Skip to main content

Table 1 Demographic and clinical characteristics of patients

From: Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients

Characteristic

Age (years), median (range)

51 (18, 76)

BMI (kg/m2), median (range)

22.1 (15.8, 34.8)

Body surface area (m2), median (range)

1.42 (1.21, 1.71)

ECOG performance status (%)

 Normal activity

56 (90.3)

 Restricted activity

6 (9.7)

Histology (%)

 High grade serous adenocarcinoma

46 (74.2)

 Mucinous adenocarcinoma

3 (4.8)

 High grade endometrioid adenocarcinoma

3 (4.8)

 Clear cell carcinoma

5 (8.1)

 Malignant mixed mullerian tumor

5 (8.1)

FIGO stage (%)

 IIIC

43 (69.4)

 IV

19 (30.7)

Surgical treatment (%)

 Primary debulking surgery

44 (71.0)

 Interval debulking surgery

18 (29.0)

Gross residual disease (%)

 Yes

43 (69.4)

 No

19 (30.7)

Surgical complexity (%)

 Low

5 (8.1)

 Moderate

40 (64.5)

 High

17 (27.4)

ICU stay (%)

 Yes

2 (3.2)

 No

60 (96.8)

Serum creatinine (umol/L), median (range)

 Prior to HIPEC

63.5 (49, 159)

 Following HIPEC

62.0 (48, 149)

Serum albumin (g/l), median (range)

 Prior to HIPEC

25 (15, 36)

 Following HIPEC

22 (15, 30)

  1. BMI Body mass index, ECOG Eastern cooperative oncology group, HIPEC Hyperthermic intraperitoneal chemotherapy, ICU Intensive care unit